Company news
Chemometec A/s (OMXCOP:CHEMM) news
Chemometec A/s news releases on 6ix. Latest, Sep 10, 2026: Guidance for the 2026/27 financial year
Press releases & updates
Guidance for the 2026/27 financial year
September 10, 2026
ChemoMetec enters collaboration agreement with Roche Diagnostics
August 10, 2026
ChemoMetec A/S invites to conference call on September 11, 2026 at 3:00 p.m. CEST on its upcoming 2025/26 Annual Report
August 7, 2026
Initiation of buy-back programme
May 15, 2026
Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance
May 4, 2026
Notification of managers’ transactions
March 27, 2026
Adjustment of guidance for 2025/26
March 24, 2026
ChemoMetec A/S : Notification of managers' transactions
March 2, 2026
ChemoMetec enters Letter of Intent with Roche Diagnostics
February 4, 2026
Interim report 2025/26 - Organic growth despite challenges in the North American market
February 4, 2026
Growth in revenue and operating profit
November 6, 2025
Upgrade of guidance
October 28, 2025
Procedure of the Annual General Meeting
October 9, 2025
ChemoMetec A/S : Annual Report 2024-25 (UK) (99f86b)
September 17, 2025
ChemoMetec A/S : Remuneration Report 2024-25 (UK) (262046)
September 17, 2025
Annual Report 2024/25 - Growing revenue and EBITDA
September 11, 2025
Guidance for the 2025/26 financial year
September 11, 2025
Preliminary revenue figures for the 2024/25 financial year
July 1, 2025
Continued growth in revenue and operating profit
May 7, 2025